Skip to main content
SpringerLink
Log in

Crizotinib/pemetrexed

Colitis, malaise and nausea: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kanai O, et al. Nasogastric tube-administered alectinib achieved long-term survival in a crizotinib-refractory nonsmall cell lung cancer patient with a poor performance status. Clinical Case Reports 5: 927-930, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1002/ccr3.973 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crizotinib/pemetrexed. Reactions Weekly 1658, 148 (2017). https://doi.org/10.1007/s40278-017-32345-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-32345-9

Search

Navigation